INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30

INTELLIGENT BIO SOLUTIONS INC.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K/A on Oct 21, 2026

$1.53+0.03 (+2.00%)

Close on Oct 19, 2026

Market cap: $3.83M
P/E (TTM): –
Dividend yield: –

INTELLIGENT BIO SOLUTIONS INC. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-06-30	FY 2025 2025-06-30	FY 2024 2024-06-30	FY 2023 2023-06-30	FY 2022 2022-06-30	FY 2021 2021-06-30	FY 2020 2020-06-30
Revenue	4.22	3.05	3.11	1.26	0.44	1.98	0.19
Cost of Revenue	2.17	1.81	1.69	0.93	–	–	–
Gross Profit	2.05	1.25	1.43	0.33	–	–	–
Selling, General & Admin	11	8.92	–	–	–	–	–
General & Administrative	11	8.92	9.26	8.03	4.92	3.36	2.20
Advertising Expenses	–	1.55	0.73	–	–	–	–
Operating Expenses	15	13	12	14	8.77	7.55	3.05
Operating Income	-13	-11	-10	-13	-8.34	-5.57	-2.86
Interest Expense	0.01	0.03	0.17	–	–	–	–
Interest & Investment Income	0.11	0.10	0.08	–	–	–	–
Income from Equity Investments	–	–	–	–	–	-0.14	0.12
Other Non-Operating Income	0.14	0.07	0.09	1.93	0.00	-1.49	-0.34
Asset Impairment Charges	–	–	–	4.16	–	–	–
Gain (Loss) on Investments	–	–	0.18	2.15	–	-0.14	0.12
Pretax Income	–	–	–	–	–	-7.06	-3.19
Net Income incl. Noncontrolling Interests	-12	-11	-10	-11	-8.33	-7.06	-3.19
Minority Interest in Earnings	-0.04	-0.04	-0.03	-0.03	-0.03	-0.02	-0.03
Net Income	-12	-11	-10	-11	-8.31	-7.04	-3.16
EPS (Basic)(per share)	-8.44	-20.04	-63.80	-1,270.00	-1,359.60	-1,632.00	-888.00
EPS (Diluted)(per share)	-8.44	-20.04	-63.80	-1,270.00	-1,359.60	-1,632.00	-888.00
Shares Outstanding (Basic, Weighted)(shares)	1.47	0.53	0.16	0.01	0.01	0.00	0.00
Shares Outstanding (Diluted, Weighted)(shares)	1.47	0.53	0.16	0.01	0.01	0.00	0.00
EBITDA	-11	-9.47	-9.31	-12	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 48.6%
Operating margin: -299.1%
Net margin: -294.9%
Return on equity, FY2026: -292.3%

Financial strength

Current ratio: 1.44
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 81.0%

Valuation

P/E ratio: –
Price to sales: 0.91
Price to book: 0.69
Dividend yield: –